Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Senti Biosciences Q3 EPS $(0.38)

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.38) per share.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.38) per share.

Goldman Sachs Maintains Neutral on Terex, Lowers Price Target to $41

By Benzinga Newsdesk

Today, 8:27 PM

Goldman Sachs maintains Terex (NYSE:TEX) with a Neutral and lowers the price target from $48 to $41.

TEX

Wedbush Maintains Outperform on Uber Technologies, Raises Price Target to $40

By Benzinga Newsdesk

Today, 8:27 PM

Wedbush analyst Daniel Ives maintains Uber Technologies (NYSE:UBER) with a Outperform and raises the price target from $38 to $40.

UBER

M&A
News

Everi Acquires Strategic Assets From Meter Image Capturing For Undisclosed Sum

By Shivani Kumaresan

Today, 8:27 PM

Everi Holdings Inc (NYSE:EVRI) has acquired certain strategic assets of Meter Image Capturing LLC (MIC), a privately-owned progressive meter reporting technology provider, for…

EVRI

HC Wainwright & Co. Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $28

By Benzinga Newsdesk

Today, 8:27 PM

HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Buy rating and announces Price Target of $28.

STTK

Senti Biosciences Q3 EPS $(0.38)

Related Posts

Goldman Sachs Maintains Neutral on Terex, Lowers Price Target to $41

Wedbush Maintains Outperform on Uber Technologies, Raises Price Target to $40

Everi Acquires Strategic Assets From Meter Image Capturing For Undisclosed Sum

HC Wainwright & Co. Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $28